...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: COLCORONA trial: Colchicine reduces the risk of COVID-19-related complications

This could be analagous to the use of apabetalone for COVID-19. However, if and when an apabetalone trial is run hopefully it achieves statistical significance for the primary endpoint.

https://www.globenewswire.com/news-release/2021/01/23/2163109/0/en/Colchicine-reduces-the-risk-of-COVID-19-related-complications.html

 

Share
New Message
Please login to post a reply